There are few clubs in the world as exclusive as The Forbes 400, and in 2025, the cost of entry has climbed higher than ever.
To secure a place among the wealthiest individuals now requires a minimum net worth of $3.8 billion, an increase of $500 million from last year, reflecting buoyant equity markets and a surge in asset values.
Despite the steep threshold, more than 90% of last year’s billionaires successfully retained their positions.
Still, over 10 new names managed to muscle their way into the elite club, reflecting both entrepreneurial agility and the market’s shifting opportunities. Their fortunes span industries as varied as coffee retail, cancer diagnostics, and the rapidly expanding artificial intelligence sector.
For the sake of this article, we will look at only 10 of these individuals. Cumulatively, these newcomers are valued at $96 billion. About three of them command individual fortunes above $10 billion, a sign that new wealth creation is accelerating at the very top of the pyramid.
The data also highlights how innovation-led industries, particularly AI, are increasingly shaping global wealth dynamics. For perspective, the combined wealth of these new entrants alone surpasses the GDP of several African economies.
- Net worth: $4.9 billion
- Source of wealth: Biotech
David Dean Halbert, 69, has spent decades betting on healthcare, and his latest wager has made him a billionaire many times over. The longtime investor is the founder and executive chairman of Caris Life Sciences, a Texas-based cancer diagnostics company that went public on Nasdaq in 2025, raising about $494 million. By mid-afternoon trading, Caris was valued at $7.4 billion, giving Halbert, who owns nearly 44% of the company, a net worth of at least $3.3 billion, according to Forbes.
Halbert first acquired the business in 2008, when it was a small startup known as Molecular Profiling Institute. He transformed it into Caris Life Sciences, which now uses gene sequencing, artificial intelligence and machine learning to detect and monitor cancer. The company generated $412 million in revenue last year, though it posted a $282 million net loss.
A graduate of Abilene Christian University, Halbert is no stranger to healthcare ventures. In 1987, he founded AdvancePCS, a pharmacy benefit manager sold to CareMark for $7.5 billion in 2004. Through his firm Caris Capital, he has invested more than $1.2 billion across industries.
Technology and Trade. The two T’s that make billionaires.